Stem Cell Therapy

  • Panneer Devaraju
  • Damayandhi Kaliyaperumal
  • Thirumurthy Madhavan


Stem cells are a reserve of unique cells with self-renewal property. It differentiates into organ-specific cells to replace the dead tissues to restore the physiological functions. Based on their ability to differentiate into the whole organism, cells of all the three germ layers, cells of particular germline, or only the target cells, they are termed as totipotent, pluripotent, multipotent, or progenitor stem cells, respectively. Based on their source, they are classified as embryonic, non-embryonic, mesenchymal, perinatal, cancer, and induced pluripotent stem cells. The self-renewal and differentiation properties of stem cells made them an ideal therapeutic tool to treat diseases associated with tissue loss. Hence, the major neurological, musculoskeletal, skin, hematological, cardiac diseases, and diabetes mellitus once thought to be nontreatable has now gained the hope of remedy on the use of organ-specific stem cells. In addition, stem cells have been engineered for targeted enzyme prodrug delivery for the treatment of deep-seated tumors like glioblastoma. The major limitation in the use of stem cells for therapy is its propensity to form teratoma and distribution in nonpreferred sites. Hence, tailoring the stem cells to reach the desired niche and to restore the physiological functions is underway to develop a promising therapeutic modality for treating the various challenging diseases in the medical field.


Stem cells Stem cell therapy Teratoma Targeted enzyme prodrug delivery 


  1. Branski LK, Gauglitz GG, Herndon DN, Jeschke MG (2009) A review of gene and stem cell therapy in cutaneous wound healing. Burns 35:171–180CrossRefGoogle Scholar
  2. Chagastelles PC, Nardi NB (2011) Biology of stem cells: an overview. Kidney Int Suppl (2011) 1:63–67CrossRefGoogle Scholar
  3. El-Badawy A, El-Badri N (2016) Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis. PLoS One 11:e0151938CrossRefGoogle Scholar
  4. Herberts CA, Kwa MSG, Hermsen HPH (2011) Risk factors in the development of stem cell therapy. J Transl Med 9:29CrossRefGoogle Scholar
  5. Hibi H, Yamada Y, Kagami H, Ueda M (2006) Distraction osteogenesis assisted by tissue engineering in an irradiated mandible: a case report. Int J Oral Maxillofac Implants 21:141–147PubMedGoogle Scholar
  6. Horwitz EM, Gordon PL, Koo WK et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937CrossRefGoogle Scholar
  7. Lindvall O, Kokaia Z (2006) Stem cell for the treatment of neurological disorders. Nature 441:1094–1096CrossRefGoogle Scholar
  8. Lucarelli G, Isgrò A, Sodani P, Gaziev J (2012) Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med 2:a011825CrossRefGoogle Scholar
  9. Morishita T et al (2006) Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients’ mesenchymal stem cells. Artif Organs 30:115–118CrossRefGoogle Scholar
  10. Segers VFM, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451:937–942CrossRefGoogle Scholar
  11. Shin TH, Kim HS, Choi SW, Kang KS (2017) Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action. Int J Mol Sci 18:pii:E244CrossRefGoogle Scholar
  12. Srivastava D, Ivey KN (2006) Potential of stem-cell-based therapies for heart disease. Nature 441:1097–1099CrossRefGoogle Scholar
  13. Tian H, Qu Q, Liu L, Wu D (2016) Advances in stem cell therapy for leukemia. Curr Stem Cell Res Ther 11:158–165CrossRefGoogle Scholar
  14. Vacanti MP, Roy A, Cortiella J, Bonassar L, Vacanti CA (2001) Identification and initial characterization of spore-like cells in adult mammals. J Cell Biochem 80:455–460CrossRefGoogle Scholar
  15. Zhang CL, Huang T, Wu BL, He WX, Liu D (2017) Stem cells in cancer therapy: opportunities and challenges. Oncotarget 8(43):75756–75766PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Panneer Devaraju
    • 1
  • Damayandhi Kaliyaperumal
    • 2
  • Thirumurthy Madhavan
    • 3
  1. 1.Vector Control Research CentrePuducherryIndia
  2. 2.Department of DermatologyAarupadai Veedu Medical College and HospitalPuducherryIndia
  3. 3.Department of Genetic EngineeringSRM UniversityChennaiIndia

Personalised recommendations